Search

Your search keyword '"Andrews, Jane M."' showing total 1,052 results
Start Over Author "Andrews, Jane M."
1,052 results on '"Andrews, Jane M."'

303. Mo2071 A Placebo Controlled Randomised Treatment Trial for Functional Dyspepsia Including Post-Treatment Drug Withdraw and Placebo Withdraw Effects

Author

Holtmann, Gerald, primary, Andrews, Jane M., additional, Holloway, Richard H., additional, Beilby, Justin, additional, Adam, Birgit, additional, Pilichiewicz, Amelia N., additional, Goess, Charlotte, additional, Fraser, Robert J., additional, Liebregts, Tobias, additional, Jones, Michael P., additional, and Talley, Nicholas J., additional

Published
2013
Full Text
View/download PDF

305. 39 Early Treatment With Immunomodulators Is Associated With Change in the Natural History of Inflammatory Bowel Disease - Multicentre Longitudinal Study -Sydney, Australia 1942-2012

Author

Kariyawasam, Viraj C., primary, Lunney, Paul C., additional, Huang, Tony D., additional, Middleton, Kate, additional, Wang, Rosy R., additional, Selinger, Christian P., additional, Katelaris, Peter, additional, Andrews, Jane M., additional, and Leong, Rupert W., additional

Published
2013
Full Text
View/download PDF

307. Sa1207 Pharmacokinetics/Pharmacodynamics (PK/PD), Efficacy, and Safety of AMG 181 in Subjects With Active, Mild to Moderate Ulcerative Colitis - An Initial Assessment

Author

Pan, Wei-Jian, primary, Radford-Smith, Graham, additional, Andrews, Jane M., additional, Schwartz, Howard I., additional, Sullivan, Barbara A., additional, Evangelista, Christine M., additional, Rees, William A., additional, Doherty, David R., additional, Prince, Peter J., additional, Reynhardt, Kai O., additional, Zhou, Kefei, additional, Johnson, Justo Sierra, additional, Treacy, Anthony M., additional, Lee, Jonathan, additional, Yu, Zhigang, additional, and Borie, Dominique C., additional

Published
2013
Full Text
View/download PDF

312. Genetic Susceptibility in IBD

Author

Doecke, James D., primary, Simms, Lisa A., additional, Zhao, Zhen Zhen, additional, Huang, Ning, additional, Hanigan, Katherine, additional, Krishnaprasad, Krupa, additional, Roberts, Rebecca L., additional, Andrews, Jane M., additional, Mahy, Gillian, additional, Bampton, Peter, additional, Lewindon, Peter, additional, Florin, Timothy, additional, Lawrance, Ian C., additional, Gearry, Richard B., additional, Montgomery, Grant W., additional, and Radford-Smith, Graham L., additional

Published
2013
Full Text
View/download PDF

313. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review

Author

Mikocka-Walus, Antonina A., Turnbull, Debora A., Moulding, Nicole T., Wilson, Ian G., Andrews, Jane M., Holtmann, Gerald J., Mikocka-Walus, Antonina A., Turnbull, Debora A., Moulding, Nicole T., Wilson, Ian G., Andrews, Jane M., and Holtmann, Gerald J.

Abstract

Psychological disorders are highly prevalent in patients with inflammatory bowel disease (IBD). Anxiety and depression are known to independently affect quality of life and may additionally impair quality of life in IBD over and above the IBD itself. Some researchers have further proposed that anxiety and depression may influence the clinical course of IBD. However, despite the potential for anxiety and depression to play an important role in the clinical picture of IBD, there is little prospective well-controlled research in this area. Probably because of this lack of clear data, researchers dispute the actual role of these psychological disorders in IBD, with a number of conflicting opinions expressed. This article reports on a review of the literature in this field. Herein we discuss the five main areas of controversy regarding IBD and the specific psychological comorbidities of depression and anxiety: 1) the relative rate of cooccurrence of these psychological disorders with IBD; 2) the cooccurrence of these psychological disorders with particular phase of IBD; 3) the cooccurrence of these psychological disorders with the specific type of IBD; 4) the rate of these psychological comorbidities compared both to healthy subjects and to other disease states; and 5) the timing of onset of psychological comorbidity with respect to onset of IBD. Methodological weaknesses of the reviewed studies make it impossible to resolve these controversies. However, the results clearly show that anxiety/depression and IBD frequently interact. Given the long-term illness burden patients with IBD face, further prospective, appropriately controlled studies are needed to adequately answer the question of the precise interplay between anxiety/depression and IBD.

Published
2007

314. 'It doesn't do any harm, but patients feel better': a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease

Author

Mikocka-Walus, Antonina, Turnbull, Deborah A., Moulding, Nicole T., Wilson, Ian G., Andrews, Jane M., Holtmann, Gerald J., Mikocka-Walus, Antonina, Turnbull, Deborah A., Moulding, Nicole T., Wilson, Ian G., Andrews, Jane M., and Holtmann, Gerald J.

Abstract

Background: Interest in psychological factors in patients with inflammatory bowel disease (IBD)has increased in recent years. It has even been proposed that treating psychological co-morbiditieswith antidepressants may control disease activity and improve quality of life. Despite this, there isno data on gastroenterologists' attitudes to, and experiences with, antidepressant therapy inpatients with IBD.Methods: We conducted semi-structured interviews with 18 gastroenterologists associated withmetropolitan teaching hospitals. Qualitative content analysis was used to examine their responses.Results: Seventy-eight percent of gastroenterologists had treated IBD patients withantidepressants for pain, depression and/or anxiety, and insomnia. Antidepressants were reportedto be useful in improving psychosocial well-being, quality of life, and self-management of the diseaseby patients. However, in this group of gastroenterologists, there appears to be skepticism towardspsychological disorders themselves or antidepressant therapy having a central role in either thecausation of IBD or its clinical course. Nevertheless, these gastroenterologists were receptive tothe idea of conducting a trial of the role of antidepressants in IBD.Conclusion: While the majority of specialists have treated IBD patients with antidepressants,there is considerable skepticism with regard to efficacy of antidepressive therapy or the role ofpsychological factors in the outcome of IBD patients.

Published
2007

315. 'It doesn't do any harm, but patients feel better': a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease

Author

Mikocka-Walus, Antonina A, Turnbull, Deborah, Moulding, Nicole T, Wilson, Ian G, Andrews, Jane M, Holtmann, Gerald J, Mikocka-Walus, Antonina A, Turnbull, Deborah, Moulding, Nicole T, Wilson, Ian G, Andrews, Jane M, and Holtmann, Gerald J

Abstract

Background: Interest in psychological factors in patients with inflammatory bowel disease (IBD) has increased in recent years. It has even been proposed that treating psychological co-morbidities with antidepressants may control disease activity and improve quality of life. Despite this, there is no data on gastroenterologists' attitudes to, and experiences with, antidepressant therapy in patients with IBD. Methods: We conducted semi-structured interviews with 18 gastroenterologists associated with metropolitan teaching hospitals. Qualitative content analysis was used to examine their responses. Results: Seventy-eight percent of gastroenterologists had treated IBD patients with antidepressants for pain, depression and/or anxiety, and insomnia. Antidepressants were reported to be useful in improving psychosocial well-being, quality of life, and self-management of the disease by patients. However, in this group of gastroenterologists, there appears to be skepticism towards psychological disorders themselves or antidepressant therapy having a central role in either the causation of IBD or its clinical course. Nevertheless, these gastroenterologists were receptive to the idea of conducting a trial of the role of antidepressants in IBD. Conclusion: While the majority of specialists have treated IBD patients with antidepressants, there is considerable skepticism with regard to efficacy of antidepressive therapy or the role of psychological factors in the outcome of IBD patients.

Published
2007

316. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review

Author

Mikocka-Walus, Antonina A, Turnbull, Deborah, Moulding, Nicole T, Wilson, Ian G, Andrews, Jane M, Holtmann, Gerald J, Mikocka-Walus, Antonina A, Turnbull, Deborah, Moulding, Nicole T, Wilson, Ian G, Andrews, Jane M, and Holtmann, Gerald J

Abstract

Psychological disorders are highly prevalent in patients with inflammatory bowel disease (IBD). Anxiety and depression are known to independently affect quality of life and may additionally impair quality of life in IBD over and above the IBD itself. Some researchers have further proposed that anxiety and depression may influence the clinical course of IBD. However, despite the potential for anxiety and depression to play an important role in the clinical picture of IBD, there is little prospective well-controlled research in this area. Probably because of this lack of clear data, researchers dispute the actual role of these psychological disorders in IBD, with a number of conflicting opinions expressed. This article reports on a review of the literature in this field. Herein we discuss the five main areas of controversy regarding IBD and the specific psychological comorbidities of depression and anxiety: 1) the relative rate of cooccurrence of these psychological disorders with IBD; 2) the cooccurrence of these psychological disorders with particular phase of IBD; 3) the cooccurrence of these psychological disorders with the specific type of IBD; 4) the rate of these psychological comorbidities compared both to healthy subjects and to other disease states; and 5) the timing of onset of psychological comorbidity with respect to onset of IBD. Methodological weaknesses of the reviewed studies make it impossible to resolve these controversies. However, the results clearly show that anxiety/depression and IBD frequently interact. Given the long-term illness burden patients with IBD face, further prospective, appropriately controlled studies are needed to adequately answer the question of the precise interplay between anxiety/depression and IBD.

Published
2007

317. Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms.

Author

McCallum, Stacey L., Andrews, Jane M., Gaughwin, Matthew D., Turnbull, Deborah A., and Mikocka-Walus, Antonina A.

Subjects
*PATIENT satisfaction, *ALCOHOL drinking & health, *ALCOHOLISM treatment, *SYMPTOMS, *COMORBIDITY, *DETOXIFICATION (Alternative medicine), *OUTPATIENT medical care
Abstract

Background: Previous studies suggest patients with co-occurring alcohol use disorders (AUDs) and severe mental health symptoms (SMHS) are less satisfied with standard AUD treatment when compared to patients with an AUD alone. This study compared patient satisfaction with standard AUD treatment among patients with and without SMHS and explored how standard treatment might be improved to better address the needs of these patients. Methods: Eighty-nine patients receiving treatment for an AUD either at an inpatient hospital, outpatient clinic, inpatient detoxification, or residential/therapeutic community services were surveyed. Patient satisfaction with treatment was assessed using the Treatment Perception Questionnaire (range: 0-40). Patients were stratified according to their score on the Depression Anxiety Stress Scale. Forty patients scored in the extremely severe range of depression (score >14) and/ or anxiety (score >10) (indicating SMHS) and 49 patients did not. An inductive content analysis was also conducted on qualitative data relating to areas of service improvement. Results: Patients with SMHS were found to be equally satisfied with treatment (mean =25.10, standard deviation =8.12) as patients with an AUD alone (mean =25.43, standard deviation =6.91). Analysis revealed that being an inpatient in hospital was associated with reduced treatment satisfaction. Patients with SMHS were found to be significantly less satisfied with staffs' understanding of the type of help they wanted in treatment, when compared to patients with AUDs alone. Five areas for service improvement were identified, including staff qualities, informed care, treatment access and continuity, issues relating to inpatient stay, and addressing patients' mental health needs. Conclusion: While findings suggest that AUD treatment services adequately meet the needs of patients with SMHS in treatment, patients with SMHS do feel that staff lack understanding of their treatment needs. Findings have important implications as to how current health care practice might be improved according to the patient's perspective of care. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

318. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.

Author

Costello, Samuel P., Tucker, Emily C., La Brooy, Justin, Schoeman, Mark N., and Andrews, Jane M.

Subjects
FECAL microbiota transplantation, CLOSTRIDIOIDES difficile, FECES examination, ORGAN donation, INFECTIOUS disease transmission, THERAPEUTICS
Abstract

Recurrent or refractory Clostridium difficile infection (CDI) has become an increasing problem in the past decade. Fecal microbiota transplant (FMT) is a highly efficacious treatment for recurrent CDI; however, a number of technical, logistical, and regulatory issues have hampered the development of an FMT capability at many hospitals. The development of a frozen stool bank of screened donor stool is an important step in the standardization of the procedure. This gives clinicians rapid access to thoroughly screened donor stool when needed, without the ethical and logistical problems associated with patient-selected donors. We describe the practicalities of establishing such a service using a stool bank of prescreened donor stool including detail regarding donor recruitment and screening, stool preparation, and delivery of the FMT. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

319. A cognitive behavioural therapy booklet for anxiety in functional gastrointestinal disorders: Patient and health practitioner perspectives.

Author

Mikocka-Walus, Antonina A., Ahl, Alyce, Gordon, Andrea L., and Andrews, Jane M.

Subjects
PSYCHOTHERAPY research, COGNITIVE therapy, PAMPHLETS, SELF-reliance, COGNITIVE-analytic therapy
Abstract

Copyright of Psychotherapy Research is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2016
Full Text
View/download PDF

320. Antidepressants and inflammatory bowel disease: a systematic review

Author

Mikocka-Walus, Antonina A, Turnbull, Deborah A, Moulding, Nicole T, Wilson, Ian G, Andrews, Jane M, Holtmann, Gerald J, Mikocka-Walus, Antonina A, Turnbull, Deborah A, Moulding, Nicole T, Wilson, Ian G, Andrews, Jane M, and Holtmann, Gerald J

Abstract

Background A number of studies have suggested a link between the patient's psyche and the course of inflammatory bowel disease (IBD). Although pharmacotherapy with antidepressants has not been widely explored, some investigators have proposed that treating psychological co-morbidities with antidepressants may help to control disease activity. To date a systematic analysis of the available studies assessing the efficacy of antidepressants for the control of somatic symptoms in IBD patients has not been performed. Methods We searched electronic databases, without any language restriction. All relevant papers issued after 1990 were examined. Results 12 relevant publications were identified. All of them referred to non-randomised studies. Antidepressants reported in these publications included paroxetine, bupropion, amitriptyline, phenelzine, and mirtazapine. In 10 articles, paroxetine, bupropion, and phenelzine were suggested to be effective for treating both psychological and somatic symptoms in patients suffering from IBD. Amitriptyline was found ineffective for treating somatic symptoms of IBD. Mirtazapine was not recommended for IBD patients. Conclusion Although most of reviewed papers suggest a beneficial effect of treatment with antidepressants in patients with IBD, due to the lack of reliable data, it is impossible to judge the efficacy of antidepressants in IBD. Properly designed trials are justified and needed based upon the available uncontrolled data.

Published
2006

322. Integrated Models of Care in Managing Inflammatory Bowel Disease: A Discussion

Author

Mikocka-Walus, Antonina A., primary, Andrews, Jane M., additional, Bernstein, Charles N., additional, Graff, Lesley A., additional, Walker, John R., additional, Spinelli, Antonino, additional, Danese, Silvio, additional, van der Woude, Janneke C., additional, Goodhand, James, additional, Rampton, David, additional, and Moser, Gabriele, additional

Published
2012
Full Text
View/download PDF

324. Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes

Author

Hughes, Patrick A, primary, Harrington, Andrea M, additional, Castro, Joel, additional, Liebregts, Tobias, additional, Adam, Birgit, additional, Grasby, Dallas J, additional, Isaacs, Nicole J, additional, Maldeniya, Lochana, additional, Martin, Chris M, additional, Persson, Jenny, additional, Andrews, Jane M, additional, Holtmann, Gerald, additional, Blackshaw, L Ashley, additional, and Brierley, Stuart M, additional

Published
2012
Full Text
View/download PDF

326. Sa1921 Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease

Author

Radford-Smith, Graham, primary, Hartnell, Felicity, additional, Jones, Lee V., additional, Krishnaprasad, Krupa, additional, Prosser, Ruth, additional, Marr, Debbie, additional, Grafton, Rachel, additional, Cooke, Sharon E., additional, Fischer, Jesse, additional, Thomas, Gareth R., additional, Grover, Zubin, additional, Lewindon, Peter, additional, Tehan, Jane V., additional, Ding, Nik S., additional, Moss, Kerrie, additional, Bell, Sally, additional, De Cruz, Peter, additional, Mahy, Gillian, additional, Sewell, Karen, additional, Croft, Anthony, additional, O'Rourke, Peter, additional, Lawrance, Ian C., additional, Bampton, Peter A., additional, Andrews, Jane M., additional, and Gearry, Richard B., additional

Published
2012
Full Text
View/download PDF

327. Sa2068 The Effect of the Probiotic Escherichia coli Nissle 1917 on Symptom Patterns and Immune Response in Patients Suffering From Diarrhoea Predominant Irritable Bowel Syndrome

Author

Pilichiewicz, Amelia N., primary, Persson, Jenny, additional, Goess, Charlotte, additional, Gapasin, Judith D., additional, Tsopelas, Chris, additional, Bartholomeusz, Dylan, additional, Bellon, Max, additional, Holtmann, Gerald, additional, Holloway, Richard H., additional, and Andrews, Jane M., additional

Published
2012
Full Text
View/download PDF

328. Mo1850 C-IBS Patients Lack Monocyte Derived β-Endorphin Which Results in Disinhibition of Colonic Afferent Mechanosensitivity

Author

Hughes, Patrick A., primary, Nicholson, Ian C., additional, Bird, Daniel, additional, To, Sarah, additional, Issacs, Nicole, additional, Grasby, Dallas J., additional, Persson, Jenny, additional, Harrington, Andrea M., additional, Brierley, Stuart M., additional, Zola, Heddy, additional, Andrews, Jane M., additional, Blackshaw, L. Ashley, additional, and Krumbiegel, Doreen, additional

Published
2012
Full Text
View/download PDF

331. Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study

Author

De Cruz, Peter, primary, Kamm, Michael A., additional, Hamilton, Amy L., additional, Ritchie, Kathryn J., additional, Gorelik, Alexandra, additional, Liew, Danny, additional, Prideaux, Lani, additional, Lawrance, Ian C., additional, Andrews, Jane M., additional, Bampton, Peter A., additional, Sparrow, Miles, additional, Jakobovits, Simon, additional, Florin, Timothy H., additional, Gibson, Peter R., additional, Debinski, Henry, additional, Gearry, Richard B., additional, Macrae, Finlay A., additional, Leong, Rupert W., additional, Kronborg, Ian, additional, Connor, Susan J., additional, Radford-Smith, Graham, additional, Selby, Warwick, additional, Johnston, Michael J., additional, Woods, Rodney, additional, Keck, James, additional, Brouwer, Richard, additional, Connell, William, additional, Brown, Steven J., additional, Bell, Sally, additional, Lust, Mark, additional, Elliott, Ross, additional, and Desmond, Paul, additional

Published
2012
Full Text
View/download PDF

332. 1161 Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study

Author

De Cruz, Peter, primary, Kamm, Michael A., additional, Hamilton, Amy L., additional, Ritchie, Kathryn J., additional, Gorelik, Alexandra, additional, Liew, Danny, additional, Prideaux, Lani, additional, Lawrance, Ian C., additional, Andrews, Jane M., additional, Bampton, Peter A., additional, Sparrow, Miles, additional, Jakobovits, Simon, additional, Florin, Timothy H., additional, Gibson, Peter R., additional, Debinski, Henry, additional, Gearry, Richard B., additional, Macrae, Finlay A., additional, Leong, Rupert W., additional, Kronborg, Ian, additional, Connor, Susan J., additional, Radford-Smith, Graham, additional, Selby, Warwick, additional, Johnston, Michael J., additional, Woods, Rodney, additional, Keck, James, additional, Brouwer, Richard, additional, Connell, William, additional, Brown, Steven J., additional, Bell, Sally, additional, Lust, Mark, additional, Elliott, Ross, additional, and Desmond, Paul, additional

Published
2012
Full Text
View/download PDF

334. Sa1282 Colectomy for Ulcerative Colitis Across Australia and New Zealand: Indications, Risk Factors and Rates - an ANZ IBD Consortium Study

Author

Radford-Smith, Graham, primary, Krishnaprasad, Krupa, additional, Andrews, Jane M., additional, Bampton, Peter A., additional, Simms, Lisa, additional, Mahy, Gillian, additional, Croft, Anthony, additional, Hartnell, Felicity, additional, Walker, Nicole M., additional, Prosser, Ruth, additional, Grafton, Rachel, additional, Leach, Peta, additional, Cooke, Sharon E., additional, Lee, Hong, additional, Visscher, Peter M., additional, Montgomery, Grant, additional, Florin, Timothy H., additional, Gearry, Richard B., additional, and Lawrance, Ian C., additional

Published
2012
Full Text
View/download PDF

335. Su1633 Placebo Effects in Functional Dyspepsia: A Preliminary Analysis on Symptoms in an Ongoing Randomized Placebo Controlled Trial

Author

Pilichiewicz, Amelia N., primary, Andrews, Jane M., additional, Goess, Charlotte, additional, McMahon, Julie, additional, Barrett, Bridgette, additional, Fraser, Robert J., additional, Beilby, Justin, additional, Holloway, Richard H., additional, Talley, Nicholas J., additional, and Holtmann, Gerald, additional

Published
2012
Full Text
View/download PDF

337. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study

Author

Krishnaprasad, Krupa, primary, Andrews, Jane M., additional, Lawrance, Ian C., additional, Florin, Timothy, additional, Gearry, Richard B., additional, Leong, Rupert W.L., additional, Mahy, Gillian, additional, Bampton, Peter, additional, Prosser, Ruth, additional, Leach, Peta, additional, Chitti, Laurie, additional, Cock, Charles, additional, Grafton, Rachel, additional, Croft, Anthony R., additional, Cooke, Sharon, additional, Doecke, James D., additional, and Radford-Smith, Graham L., additional

Published
2012
Full Text
View/download PDF

338. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Author

Goel, Gautam, King, Tim, Daveson, A James, Andrews, Jane M, Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J E, Fogel, Ronald, Barish, Charles F, Epstein, Roger, Kinney, Timothy P, Miner, Philip B, Tye-Din, Jason A, Girardin, Adam, Taavela, Juha, Popp, Alina, Sidney, John, Mäki, Markku, Goldstein, Kaela E, Griffin, Patrick H, Wang, Suyue, Dzuris, John L, Williams, Leslie J, Sette, Alessandro, Xavier, Ramnik J, Sollid, Ludvig M, Jabri, Bana, and Anderson, Robert P

Abstract

A gluten-free diet is the only means to manage coeliac disease, a permanent immune intolerance to gluten. We developed a therapeutic vaccine, Nexvax2, designed to treat coeliac disease. Nexvax2 is an adjuvant-free mix of three peptides that include immunodominant epitopes for gluten-specific CD4-positive T cells. The vaccine is intended to engage and render gluten-specific CD4-positive T cells unresponsive to further antigenic stimulation. We assessed the safety and pharmacodynamics of the vaccine in patients with coeliac disease on a gluten-free diet.

Published
2017
Full Text
View/download PDF

343. Smoking Cessation Following the Diagnosis of Crohn's Disease Still Reduces the Rates of Surgery and Complicated Disease

Author

Lawrance, Ian C., primary, Batman, Birol, additional, Gearry, Richard B., additional, Grafton, Rachel, additional, Krishnaprasad, Krupa, additional, Andrews, Jane M., additional, Prosser, Ruth, additional, Bampton, Peter A., additional, Cooke, Sharon E., additional, Mahy, Gillian, additional, Radford-Smith, Graham, additional, Croft, Anthony, additional, and Hanigan, Katherine, additional

Published
2011
Full Text
View/download PDF

344. Cytokine Modulation of Visceral Afferents via Cation Channels is Switched in Chronic Visceral Hypersensitivity

Author

Hughes, Patrick A., primary, Harrington, Andrea, additional, Brierley, Stuart M., additional, Maldeniya, Lochana, additional, Martin, Chris, additional, Persson, Jenny, additional, Liebregts, Tobias, additional, Adam, Birgit, additional, Holtmann, Gerald, additional, Andrews, Jane M., additional, and Blackshaw, L. Ashley, additional

Published
2011
Full Text
View/download PDF

345. Prospective Evaluation of Early Post-Operative Crohn's Recurrence in the Presence of Optimal Drug Therapy – Is Endoscopic Evaluation Worthwhile?

Author

De Cruz, Peter P., primary, Kamm, Michael A., additional, Hamilton, Amy L., additional, Ritchie, Kathryn J., additional, Prideaux, Lani, additional, Lawrance, Ian C., additional, Bampton, Peter A., additional, Andrews, Jane M., additional, Sparrow, Miles, additional, Jakobovits, Simon, additional, Gibson, Peter R., additional, Connell, William, additional, Brown, Steven J., additional, Bell, Sally, additional, Elliott, Ross, additional, and Desmond, Paul, additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results